LY2090314
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY2090314, covering 2018-11-19 to 2019-02-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY2090314 in Patients With Advanced or Metastatic Cancer [Phase 1]